Laddar...
Disseminated intravascular coagulation following administration of sunitinib
Sunitinib is an increasingly used, orally administered targeted therapy, approved by the European Medicines Agency for the treatment of various types of cancer, including gastrointestinal stromal tumor unresectable or metastatic disease, following disease progression or intolerance to imatinib, and...
Sparad:
| I publikationen: | Mol Clin Oncol |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
D.A. Spandidos
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4906963/ https://ncbi.nlm.nih.gov/pubmed/27330781 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.896 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|